Not all cancer therapies are successful, but cancer researchers increasingly are able to identify the right treatments for the right patients at the right time. A researcher at the University of Oklahoma has helped lead a ...
Mar 21, 2024
0
30
Researchers have found new disrupted genes and an unexpected molecular pattern—dubbed BREACHes—related to fragile X syndrome (FXS), a genetic disorder estimated by the Centers for Disease Control and Prevention to impact ...
Dec 27, 2023
0
36
In a study, published in American Journal of Hematology, Mayo Clinic researchers examined telomere biology disorders, a group of rare genetic disorders characterized by short telomeres.
Oct 12, 2023
0
25
Esophageal adenocarcinoma (EAC) is a highly lethal cancer, with a five-year survival rate of less than 20%. Although a precursor lesion to EAC, called Barrett's esophagus (BE), is present in roughly 7% of middle-aged adults, ...
Jul 27, 2023
0
19
A team of researchers from the University of Maryland School of Maryland's (UMSOM) Institute of Human Virology (IHV), a Center of Excellence of the Global Virus Network (GVN), published new findings that emphasize the crucial ...
Jul 17, 2023
0
40
A new clinical and preclinical study from UCLA Jonsson Comprehensive Cancer Center identifies the DNA roots of resistance to targeted cancer therapy, providing a possible strategy to address a vexing issue in cancer therapeutics. ...
Jan 26, 2023
0
51
Mutations occur in various tissues and organs of an individual. Somatic mutations occur in cells that will not give rise to offspring and are therefore not passed on to subsequent generations. Caused by a large number of ...
Jul 5, 2022
0
294
Scientists have found a way to identify and interpret 'signatures' that reveal the complex genetic causes of some of the deadliest cancers—which often have a survival rate of less than 10%. The results, published today ...
Jun 15, 2022
0
52
Researchers have developed a new integrated genetic/epigenetic DNA-sequencing protocol known as MultiMMR that can identify the presence and cause of mismatch repair (MMR) deficiency in a single test from a small sample of ...
Jan 21, 2021
0
5
A large international trial involving UCL and University College London Hospitals NHS Foundation Trust (UCLH) has found that pembrolizumab, a form of immunotherapy, more than doubled the 'progression free survival' time of ...
May 29, 2020
0
3
